The role of Fas ligand and transforming growth factor β in tumor progression
Ryungsa Kim(Hiroshima Institute of Technology), Tetsuya Toge(Hiroshima University), Kazuaki Tanabe(Hiroshima University), Yoko Uchida(Gunma University), Manabu Emi(Hiroshima University)
Cited by 135
Related Papers
Cancer immunoediting from immune surveillance to immune escape
|Immunology|2007|1k
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
The long-term survival of stage IV gastric cancer patients with conversion therapy
|Gastric Cancer|2017|168
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
|International Journal of Cancer|1992|111